Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

Market: Pharmaceuticals and Healthcare

Global, 228 pages report, published by GBI Research

Report ThumbnailDecember-2017
Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

Summary

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque build u

Read More
  • 1.2 List of Figures
  • Figure 1: Cardiovascular Disease Drugs Market, Global, Epidemiology Patterns for Hypertension, 2016-2023 24
  • Figure 2: Cardiovascular Disease Drugs Market, Global, Epidemiology Patterns for Dyslipidemia, 2016-2023 25
  • Figure 3: Cardiovascular Disease Drugs Market, Global, Epidemiology Patterns for Heart Failure, 2016-2023 26
  • Figure 4: Cardiovascular Disease Drugs Market, Global, Key Marketed Products and Approved Indications, 2017 37
  • Figure 5: Cardiovascular Disease Drugs Marke
Read More
  • 1.1 List of Tables
  • Table 1: Cardiovascular Disease Drugs Market, US, Systolic and Diastolic Blood Pressure Level and Corresponding Category, 2017 13
  • Table 2: Cardiovascular Disease Drugs Market, Global, Total Cholesterol, LDL and HDL Levels and Corresponding Category, 2017 14
  • Table 3: Cardiovascular Disease Drugs Market, Global, Approved Indications for Lipitor, 2017 38
  • Table 4: Cardiovascular Disease Drugs Market, Global, Approved Indications for Crestor, 2017 39
  • Table 5: Cardiovascular Disease
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 7
  • 1.2 List of Figures 8
  • 2 Introduction 11
  • 2.1 Therapy Area Introduction 11
  • 2.2 Symptoms 12
  • 2.3 Diagnosis 13
  • 2.3.1 Hypertension 13
  • 2.3.2 Dyslipidemia 14
  • 2.3.3 Imaging Tests 15
  • 2.3.4 Stress Testing 15
  • 2.4 Etiology, Pathophysiology, Comorbidities and Complications 16
  • 2.4.1 Hypertension 17
  • 2.4.2 Dyslipidemia 19
  • 2.4.3 Heart Failure 21
  • 2.4.4 Thrombosis 21
  • 2.5 Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation 23
  • 2.5.1
Read More

Related Products

GBI ResearchGlobal Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive LandscapeProduct ThumbnailGlobal Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape, Industry ReportProduct #: 1121868
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved